September 2, 2011 — Magnetic resonance imaging (MRI) assessment of rectal tumors before surgery predicts both disease-free and overall survival, which ultimately might help clinicians provide ...

Rectal cancer is relatively common, with about 46,220 new cases diagnosed in the United States each year (27,330 in men and 18,890 in women), according to the American Cancer Society.

Magnetic Resonance Imaging–Detected Tumor Response for Locally Advanced Rectal Cancer Predicts Survival Outcomes: MERCURY Experience. Journal of Clinical Oncology, 2011; DOI: 10.1200/JCO.2011.34 ...

This study included 79 patients who had T3 or T4 and/or N+ rectal cancer treated with long-course neoadjuvant chemoradiation. MRI-assessed tumor regression grade (mrTRG) was assessed in 64 patients.

Predicting treatment response for the safe non-operative management of patients with rectal cancer using an MRI-based deep-learning model. Authors: Heather M. Selby, Charles Liu, Vipul Sheth, Sandy ...

June 15, 2015 0 Value of 18F-FDG PET for Predicting Response to Neoadjuvant Therapy in Rectal Cancer: Systematic Review and Meta-analysis Maffione AM, Marzola MC, Capirci C, Colletti PM, Rubello D ...

Clinical complete response is defined by endoscopy, digital rectal exam, and rectal MRI. The first 18 patients had a median age of 54, and women accounted for 12 of the patients.

In total, they reviewed outcomes from 277 patients, with an average age of 58, who had the stage of their rectal cancer determined by MRI. The average length of the follow-up period was slightly ...

Disease-free survival (DFS) at five years was 67.2 percent for MRI-clear CRM versus 47.3 percent for MRI-involved CRM (hazard ratio, 1.65). For MRI-involved CRM, local recurrence (LR) was 3.50.

The study included 39 patients (23 men, 15 women), who underwent 3T MRI. According to the study, rectal carcinoma was identified on MRI and confirmed histologically in all 39 patients.

Rectal cancer is relatively common, with about 46,220 new cases diagnosed in the United States each year (27,330 in men and 18,890 in women), according to the American Cancer Society.